Pharmacokinetics of a novel human intravenous immunoglobulin 10% in patients with primary immunodeficiency diseases: Analysis of a phase III, multicentre, prospective, open-label study.

Pharmacokinetics of a novel human intravenous immunoglobulin 10% in patients with primary immunodeficiency diseases: Analysis of a phase III, multicentre, prospective, open-label study. Eur J Pharm Sci. 2018 Jun 15; 118:80-86.

View in: PubMed

subject areas

Adolescent
Adult
Agammaglobulinemia
Aged
Child
Child, Preschool
Common Variable Immunodeficiency
Female
Genetic Diseases, X-Linked
Humans
Immunoglobulin G
Immunoglobulins, Intravenous
Male
Middle Aged
Young Adult

authors with profiles

James Moy